BERKELEY HEIGHTS, N.J., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders will announce second quarter 2013 financial results on Wednesday, August 14, 2013. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
|Conference call information:|
|US/Canada call: (877) 493-9121/ international call: (973) 582-2750|
|US/Canada archive: (800) 585-8367 / international archive: (404) 537-3406|
|Code for live and archived conference call is 27460381|
CONTACT: Cyclacel Pharmaceuticals, Inc. Investors/Media: Paul McBarron, (908) 517-7330, firstname.lastname@example.org